Integrative Practitioner Digital Summit
IMMUNITY - JUNE 14

COVID-19 Long-Haul Syndrome: Where We Are Now

In an update to his informative and illuminating panel on post-COVID-19 syndrome at the Integrative Healthcare Symposium, David Brady, ND, DC, CCN, DACBN, IFMCP, is with us to share the latest research and developments regarding this complex, multi-factorial phenomenon known as long-haul syndrome.

There are millions of people suffering from ongoing persistent fatigue and malaise, joint pain and body aches, tachycardia, headaches, brain-fog, strange neurological symptoms, and many more problems long after the initial illness associated with SARS-CoV2 has passed.

It is becoming very clear that long-haul syndrome is a complex entity and may represent the result of a "perfect storm" of biological and environmental factors and that a systems-biology approach, utilizing a wider-lens perspective, will be required as these subjects are approached clinically. There are considerable gaps between the focus of the initial research into this phenomenon and the current approach to these conditions in standard clinical medicine, with standard interventions based predominantly on symptom control.

This presentation will review the emergence of long-haul syndrome, as well as various hypotheses proposed to explain this emerging post-pandemic epidemic. Brady will explore why some go on to suffer from long-term symptoms, and many do not. He will also discuss the role of the immune system and its complicated reaction and adaptations to SARS-CoV-2. In addition, Brady will share treatment ideas and protocols that he’s implemented in his own practice.

Upon completion of this session, participants will be able to:

  1. Appreciate the current epidemiologic trends in post-COVID long-haul syndrome.
  2. Understand the linkage and association between long-haul and factors including immunological cytokine patterns, vascular abnormalities, the GI microbiota, ongoing stealth infections, molecular mimicry, and other elements.
  3. Appreciate the available emerging clinical laboratory testing related to long-haul diagnosis, and clinical management, including complex cytokine pattern analysis, qPCR molecular-based evaluation of the GI microbiota, antigen testing, and others.
  4. Understand the available evidence-based drug, nutritional, lifestyle and complementary therapeutic interventions for long-haul syndrome/PASC.
  5. Become enlightened on the “patient experience” and strategies of collaborative care for patients with long-haul syndrome.
David Brady, ND, DC, CCN, DACBN, IFMCP, FACN

Speaker: David Brady, ND, DC, CCN, DACBN, IFMCP, FACN

David Brady, ND, DC, CCN, DACBN, IFMCP, FACN has over 30 years of experience as an integrative practitioner and over 25 years in health sciences academia. He is a licensed naturopathic medical physician in Connecticut and Vermont, is board certified in functional medicine and clinical nutrition, a fellow of the American College of Nutrition. Brady is a founder and chief medical officer for Diagnostic Solutions Labs, LLC, where he is involved in the development and the education of practitioners in the clinical implementation of a multitude on omics-based testing. He has also been the chief medical officer of Designs for Health, Inc. since 2003 and has been a guiding presence in product formulation and design, clinical education and support, quality control oversight and strategic partnerships for the company. He is the former long-term vice president of the Division of Health Sciences and director of the Human Nutrition Institute at the University of Bridgeport in Connecticut, where he continues to serve as director and professor emeritus of nutrition. He has appeared on the plenary speaking panel of some of the largest and most prestigious conferences in the field including, IFM, ACAM, A4M, ACN, IHS, AANP, AIHM and many more. He is in clinical practice at Whole Body Medicine in Fairfield, CT, specializing in functional, nutritional, and naturopathic medicine.

 

RETURN TO THE AGENDA